- Apadaz https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/208653s000lbl.pdf#page=35 - Brilinta https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/022433s022lbl.pdf#page=25 - Simponi https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2017/125433s020s021lbl.pdf# page=32 - Depakene https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Depakote ER https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/018723s060,019680s047lbl. pdf#page=97 - Steglujan https://www.accessdata.fda.
gov/drugsatfda_docs/label/ 2018/209805s001lbl.pdf#page=32
jueves, 15 de marzo de 2018
Drug Safety and Availability > Medication Guides
Drug Safety and Availability > Medication Guides
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario